Publication | Open Access

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma

Tumor BiologyBraf‐targeted TherapyMedicineMelanomaImmunologyTumor ImmunityCancer Cell BiologyImmune Checkpoint InhibitorCancer BiologyCell BiologyTumor MicroenvironmentCancer ResearchTumor Cell Adaptation